Purchase Order 36C26225P1548
Award Date
6/27/25
Potential Completion Date
6/26/26
Potential Value
$137K
Federal Agency
Veterans Integrated Service Network 22
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
VETERANS ADMINISTRATION, CA 90073, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $40,536.75, was issued by the Veterans Integrated Service Network 8 (VISN 8) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for the provision of products and services related to gene mutation JAK2 testing, a type of molecular diagnostics. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing structure. It does not have a set-aside designation. Qiagen, which has a history...
This is a $92,300.73 firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and scientific reagents. The contract is for the delivery of reagents and consumables, including Ipsogen JAK2 Mutascreen Kits and EZ1 Virus Mini Kits, to support flow cytometry specimen processing at the South Texas Veterans Healthcare System. The contract has a performance period...
Qiagen, LLC was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract value is $4,033.02 to provide genetic mutation JAK2 CPT testing services under the BPA. Performance will take place in Germantown, Maryland through December 1, 2022. No set-aside designation was used for this award. Qiagen, LLC is a subsidiary of Qiagen N.V. and will serve as the prime...
Qiagen, LLC was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. The contract value is $40,536.75 to provide products and services supporting genetic mutation testing for JAK2 CPT under the BPA. Performance will occur in Germantown, Maryland. No set aside designation was used for this award made on October 1, 2021 with a completion date of January 11, 2023. Qiagen,...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $18,498.00 contract is for the provision of reagents and supplies over a 7-month period ending on September 30, 2023. Qiagen is an established federal contractor, holding several indefinite delivery vehicles with agencies like the VA and Defense Health Agency to provide...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VA - VHA) awarded a $580,772.52 Purchase Order contract to Qiagen, LLC, a division of Qiagen N.V., for reagents. The place of performance is the Veterans Administration facility located in West Los Angeles, California. The contract start date is June 6, 2022 and ends on May 31, 2024. The pricing structure is Firm Fixed Price. No subcontractors were identified.</p>
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer, under the VA's Medical and Surgical Products and Services (FSS-65-VII) schedule contract. The order is for QuantiFERON TB reagents, with a ceiling value of $253,316.50 and a period of performance through March 10, 2017. Qiagen is an established federal contractor, providing a range of products and services to support biomedical research, public health, and...
This is a firm fixed price BPA call task order awarded to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The contract, valued at $84,105.00, is for the procurement of QuantiFERON reagents by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 (VISN 19). The contract has an ultimate completion date of August 31, 2026. Qiagen has established itself as a critical supplier of advanced...
This is a $490,745.00 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 8 (VISN 8), a civilian agency within the U.S. Department of Veterans Affairs, to Qiagen, LLC. The contract is for the provision of QIAGEN REAGENTS and has a performance period through September 30, 2026. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a history of federal contract awards across various agencies to support biomedical research,...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 22 of the U.S. Department of Veterans Affairs to Qiagen, LLC for the provision of QuantiFERON TB reagents. The contract has a ceiling value of $157,879.35 and a period of performance through March 31, 2017. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academia. Qiagen has provided a range...